MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis

Phase 3
Completed
Conditions
Blepharitis
Interventions
First Posted Date
2010-04-13
Last Posted Date
2012-06-11
Lead Sponsor
Alcon Research
Target Recruit Count
122
Registration Number
NCT01102244
Locations
🇺🇸

Ora, Andover, Massachusetts, United States

Changes in Invitro and ex Vivo Lens Metrology With Daily Wear Contact Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Acuvue 2
Device: Purevision
Device: Air Optix Aqua
Device: Biofinity
Device: Proclear
Device: Acuvue Oasys
First Posted Date
2010-04-09
Last Posted Date
2012-07-18
Lead Sponsor
Alcon Research
Target Recruit Count
35
Registration Number
NCT01100411
Locations
🇦🇺

Institute for Eye Research, Sydney, New South Wales, Australia

Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining

Not Applicable
Completed
Conditions
Corneal Staining
Interventions
Device: Opti-Free RepleniSH
Device: ReNu MultiPlus
Device: Balafilcon A
Other: Unisol 4
First Posted Date
2010-04-09
Last Posted Date
2012-10-23
Lead Sponsor
Alcon Research
Target Recruit Count
60
Registration Number
NCT01100424
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects

Phase 4
Completed
Conditions
Dry Eye
Interventions
Other: Systane Ultra Lubricant Eye Drops
First Posted Date
2010-03-15
Last Posted Date
2012-02-02
Lead Sponsor
Alcon Research
Target Recruit Count
10
Registration Number
NCT01086774

Evaluation of FID 114657 in Dry Eye Subjects

Not Applicable
Completed
Conditions
Meibomian Gland Dysfunction
Interventions
Other: FID 114657 (ORB Preserved Ocular Emulsion)
First Posted Date
2010-03-03
Last Posted Date
2012-02-02
Lead Sponsor
Alcon Research
Target Recruit Count
49
Registration Number
NCT01079858

Evaluation of FID 114657 in Sjogren's Syndrome Subjects

Not Applicable
Completed
Conditions
Sjogren's Syndrome
Interventions
Other: FID 114657 (ORB Preserved Ocular Emulsion)
First Posted Date
2010-03-03
Last Posted Date
2012-02-02
Lead Sponsor
Alcon Research
Target Recruit Count
50
Registration Number
NCT01079871

Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Eye Ointment

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: Refresh PM Ointment
Other: Lubricant eye drop FID 115958D
First Posted Date
2010-02-26
Last Posted Date
2012-02-02
Lead Sponsor
Alcon Research
Target Recruit Count
24
Registration Number
NCT01076998

Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Lubricant Eye Gel

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: Lubricant eye drop FID 115958D
Other: GenTeal Gel
First Posted Date
2010-02-26
Last Posted Date
2016-11-21
Lead Sponsor
Alcon Research
Target Recruit Count
25
Registration Number
NCT01077011

Visual Function After Implantation of AcrySof® Toric Lens

Phase 4
Terminated
Conditions
Cataract
Interventions
Device: AcrySof Toric Intraocular Lens
First Posted Date
2010-02-24
Last Posted Date
2012-09-19
Lead Sponsor
Alcon Research
Target Recruit Count
56
Registration Number
NCT01074606

Safety and Efficacy of Moxidex Otic

Phase 3
Terminated
Conditions
Acute Otitis Media
Interventions
Drug: Moxidex otic solution
Other: Vehicle
Device: Tympanostomy tubes
First Posted Date
2010-02-19
Last Posted Date
2012-12-03
Lead Sponsor
Alcon Research
Target Recruit Count
400
Registration Number
NCT01071902
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath